Artificial intelligence in the pharmaceutical galenic field: A useful instrument and risk consideration

It is undeniable that artificial intelligence technology helps humans in many fields but it is necessary to consider the risk of unprofessional use. Today, in the healthcare system, the use of artificial intelligence is widely diffused and in the future probably it will increase. Literature reports the accurancy of the various artificial intelligence tools like chatbots in some medical fields. This article aims to verify some relevant literature about this field and to test one famous provider of artificial intelligence Chatbots: Based on the results of this test some crucial considerations are submitted to the researcher. A rigorous evaluation of the benefits and risks must be considered at this level of technology and today available.

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-04-22
DOI
https://doi.org/10.5281/zenodo.15259824
Primary Topic
Chronic Myeloid Leukemia Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Artificial intelligence in the pharmaceutical galenic field: A useful instrument and risk consideration

Zenodo (CERN European Organization for Nuclear Research)
Chronic Myeloid Leukemia Treatments
article

Artificial intelligence in the pharmaceutical galenic field: A useful instrument and risk consideration

article en

Abstract

It is undeniable that artificial intelligence technology helps humans in many fields but it is necessary to consider the risk of unprofessional use. Today, in the healthcare system, the use of artificial intelligence is widely diffused and in the future probably it will increase. Literature reports the accurancy of the various artificial intelligence tools like chatbots in some medical fields. This article aims to verify some relevant literature about this field and to test one famous provider of artificial intelligence Chatbots: Based on the results of this test some crucial considerations are submitted to the researcher. A rigorous evaluation of the benefits and risks must be considered at this level of technology and today available.

Zenodo (CERN European Organization for Nuclear Research)
American Society of Consultant Pharmacists (US)
Openalex Percentile: Top 36%
Chronic Myeloid Leukemia Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.